Skip to main content

Table 3 Trends of treatment outcomes, treatment regimens and pulmonary tuberculosis patients type of patients in Anqing, China, 2005–2013 (n = 22,998)

From: Treatment outcomes and factors affecting unsuccessful outcome among new pulmonary smear positive and negative tuberculosis patients in Anqing, China: a retrospective study

Variables 2005 (n = 1631) 2006 (n = 1576) 2007 (n = 1870) 2008 (n = 3267) 2009 (n = 3134) 2010 (n = 3499) 2011 (n = 2739) 2012 (n = 2861) 2013 (n = 2421)
Successful 1543 (94.60) 1484 (94.16) 1799 (96.20) 3111 (95.22) 2992 (95.47) 3307 (94.51) 2619 (95.62) 2708 (94.65) 2288 (94.51)
 Cured 1439 (88.23) 1255 (79.63) 1248 (66.74) 2350 (71.93) 2107 (67.23) 2106 (60.19) 1572 (57.39) 1052 (36.77) 874 (36.10)
 Treatment completed 104 (6.38) 229 (14.53) 551 (29.47) 761 (23.29) 885 (28.24) 1201 (34.32) 1047 (38.23) 1656 (57.88) 1414 (58.41)
Unsuccessful 88 (5.40) 92 (5.84) 71 (3.80) 156 (4.78) 142 (4.53) 192 (5.49) 120 (4.38) 153 (5.35) 133 (5.49)
 Failure 18 (1.10) 12 (0.76) 6 (0.32) 12 (0.37) 20 (0.64) 26 (0.74) 6 (0.22) 10 (0.35) 16 (0.66)
 Death 22 (1.35) 14 (0.89) 14 (0.75) 18 (0.55) 16 (0.51) 21 (0.60) 18 (0.66) 18 (0.63) 16 (0.66)
 Default 4 (0.25) 10 (0.63) 7 (0.37) 41 (1.25) 38 (1.21) 70 (2.00) 47 (1.72) 58 (2.03) 55 (2.27)
 Transferred out 44 (2.70) 56 (3.55) 44 (2.35) 85 (2.60) 68 (2.17) 75 (2.14) 49 (1.79) 67 (2.34) 46 (1.90)
Regimens
 Regimen 1a 1631 1576 1870 2864 (87.66) 3005 (95.88) 3448 (98.54) 1837 (67.07) 692 (24.19) 658 (27.18)
 Regimen 2b 0 0 0 403 (12.34) 129 (4.12) 51 (1.46) 902 (32.93) 2169 (75.81) 1763 (72.82)
Patients type
 PTB+ 1526 (93.56) 1348 (85.53) 1298 (69.41) 2488 (76.16) 2203 (70.29) 2252 (64.36) 1660 (60.61) 1128 (39.43) 939 (38.79)
 PTB- 105 (6.44) 228 (14.47) 572 (30.59) 779 (23.84) 931 (29.71) 1247 (35.64) 1079 (39.39) 1733 (60.57) 1482 (61.21)
  1. PTB+: Smear-positive pulmonary tuberculosis patients
  2. PTB-: Smear-negative pulmonary tuberculosis patients
  3. a2H3R3Z3E3/4H3R3. R = rifampicin; H = isoniazid; Z = pyrazinamide; E = ethambutol. It means once-every-other-day HRZE for 2 months followed by 4 months of once-every-other-day HR
  4. b2HRZE/4HR. It means daily HRZE for 2 months followed by 4 months of daily HR